Mitchell A Olman Selected Research

Mitchell A Olman Research Topics

Disease

7	Acute Lung Injury 01/2020 - 03/2002
6	Fibrosis (Cirrhosis) 11/2019 - 09/2003
4	Idiopathic Pulmonary Fibrosis 03/2020 - 05/2010
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017 - 07/2009
4	Pulmonary Edema 01/2008 - 03/2002
3	Neoplasms (Cancer) 01/2017 - 10/2003
2	Asthma (Bronchial Asthma) 01/2021 - 01/2017
2	Inflammation (Inflammations) 01/2020 - 03/2002
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 01/2017
2	Lung Injury 01/2016 - 02/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 01/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2011 - 10/2003
1	Respiratory Syncytial Virus Infections 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Infections 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2019
1	Weight Loss (Weight Reduction) 12/2019
1	Venous Thromboembolism 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Cicatrix (Scar) 01/2015
1	Edema (Dropsy) 07/2003

Drug/Important Bio-Agent (IBA)

3	CationsIBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
2	CytokinesIBA 01/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2013
2	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2013 - 05/2010
2	Small Interfering RNA (siRNA)IBA 01/2011 - 10/2003
2	Phosphotransferases (Kinase)IBA 05/2010 - 10/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2009 - 09/2003
2	ProstaglandinsIBA 12/2009 - 01/2008
1	Nerve Growth Factor (NGF)IBA 01/2021
1	CalciumIBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 03/2020
1	Matrix Metalloproteinases (MMPs)IBA 03/2020
1	CatecholaminesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	Dual Specificity Phosphatase 1IBA 01/2020
1	pirfenidoneIBA 12/2019
1	nintedanibIBA 12/2019
1	cyclopropapyrroloindoleIBA 12/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2016
1	Macrophage Migration-Inhibitory FactorsIBA 01/2015
1	AnticoagulantsIBA 02/2014
1	FAK-related nonkinaseIBA 05/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2013
1	Adenosine (Adenocard)FDA LinkGeneric 01/2013
1	Warfarin (Coumadin)FDA LinkGeneric 07/2012
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 05/2010
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	Dinoprostone (PGE2)FDA Link 01/2008
1	Biomarkers (Surrogate Marker)IBA 10/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2004
1	Interleukin-6 (Interleukin 6)IBA 02/2004
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2003
1	IntegrinsIBA 10/2003
1	Integrin alpha ChainsIBA 10/2003
1	Integrin alphaVbeta3IBA 10/2003
1	integrin alphaVbeta5IBA 10/2003
1	Laminin (Merosin)IBA 10/2003
1	src-Family KinasesIBA 10/2003
1	VitronectinIBA 10/2003
1	CollagenIBA 10/2003
1	Platelet-Derived Growth FactorIBA 10/2003
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2003
1	Plasminogen Activator Inhibitor 1IBA 07/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2003
1	AntigensIBA 07/2003
1	MitogensIBA 03/2002
1	Interleukin-1 (Interleukin 1)IBA 03/2002

Therapy/Procedure

3	Therapeutics 12/2019 - 02/2014
1	Lung Transplantation 01/2018